Today: 3 May 2026
Apple stock price slips into holiday week as India antitrust warning and earnings near
17 January 2026
2 mins read

Apple stock price slips into holiday week as India antitrust warning and earnings near

New York, Jan 17, 2026, 07:40 EST — Market closed.

  • Apple shares closed Friday roughly 1% lower, at $255.53, ahead of Monday’s U.S. market holiday for MLK Day
  • India’s competition watchdog said it will move forward with an App Store case if Apple fails to respond by next week
  • Antitrust actions targeting Google’s search dominance in the U.S. might also impact payments linked to Apple’s default search agreement

Apple Inc shares slipped on Friday, closing at $255.53 as investors digested a fresh antitrust warning from India ahead of the upcoming U.S. trading session.

The timing couldn’t be more inconvenient. U.S. markets close Monday for Martin Luther King Jr. Day, squeezing the week and spotlighting just a few key dates and court filings.

Apple’s legal risks have resurfaced, not only in India but also in Washington. Efforts to challenge Alphabet’s Google have consistently highlighted the huge sums Apple pockets for default search placement.

Wall Street gave little clue on where it’s headed as the weekend approached. The S&P 500 edged down 0.1% on Friday, and the Nasdaq Composite also lost 0.1%. All three major U.S. indexes finished the week in the red, the Associated Press reported.

Apple shares (AAPL.O) fluctuated between $254.93 and $258.90 on Friday, with roughly 72 million shares traded, market data showed.

India’s Competition Commission issued a confidential Dec. 31 order, seen by Reuters, delivering a final warning to Apple. It said it would move forward with an antitrust case unless Apple responds by next week. The regulator pointed to “repeated extensions,” while Apple warns that potential penalties tied to “global turnover” — or worldwide sales — could top $38 billion. A source close to the issue said Apple probably won’t reply before a Jan. 27 hearing at the Delhi High Court. Reuters

In a separate U.S. antitrust case, Google has asked a judge to delay sharing data with competitors while it appeals a ruling that found it to hold an illegal monopoly in online search, Reuters reported late Friday. The Justice Department and a coalition of states have until Feb. 3 to decide whether to appeal a ruling that dismissed stricter remedies, including a demand that Google stop paying Apple and others to be the default search engine on new devices.

Options trading suggests jitters ahead of Apple’s upcoming earnings. Implied volatility, which shows how much movement traders anticipate, has spiked in short-term Apple contracts, Nasdaq said in a market note.

After a strong rally, some investors are growing cautious about whether large-cap tech stocks have already priced in too much good news. “Tech valuations were getting a little too far ahead of themselves,” said Alan Lancz, president of Alan B. Lancz & Associates, in a Reuters markets wrapup this week. Reuters

Legal timelines often shift, and remedies can morph quickly as judges and regulators weigh in. Either lawsuit could stretch out, but headline risk usually hits the stock hard initially—especially during shortened trading weeks.

Apple will release its quarterly earnings and hold a conference call on Jan. 29 at 5 p.m. ET (2 p.m. PT), the company confirmed.

Stock Market Today

  • Progressive (PGR) Shares Seen as Undervalued After 1-Year Price Slide
    May 2, 2026, 6:12 PM EDT. Progressive's stock recently closed at $199.31, reflecting a 25% decline over the past year despite strong gains of 68.4% and 111.9% over three and five years respectively. The insurer's valuation score stands at 4 out of 6, sparking debate over its true market worth. An Excess Returns model, which compares returns on equity against the cost of equity, estimates an intrinsic share value of $432.23, suggesting the stock is undervalued by 53.9%. This contrasts with the share price slide amid evolving market conditions and investor concerns about growth and risk. The price-to-earnings ratio also remains pivotal in assessing what investors are currently willing to pay for Progressive's profits.

Latest article

Citigroup Stock’s Big Week: Fitch Turns Positive, and Jane Fraser Gets One More Test

Citigroup Stock’s Big Week: Fitch Turns Positive, and Jane Fraser Gets One More Test

2 May 2026
Fitch Ratings revised its outlook on Citigroup to positive, affirming its issuer ratings at A and F1. Citi reported Q1 net income of $5.8 billion on $24.6 billion revenue, with a 13.1% return on tangible common equity. Shares closed Friday at $127.44, valuing the bank at $237.4 billion. Citi said it returned $7.4 billion to shareholders in Q1 through buybacks and dividends.
MP Materials Stock Faces Rare Earth Test as China Supply Signals Shift Before Earnings

MP Materials Stock Faces Rare Earth Test as China Supply Signals Shift Before Earnings

2 May 2026
MP Materials will report first-quarter earnings on May 7 after market close. China shipped 60 tons of yttrium oxide to the U.S. in March, but annual U.S. imports remain down 75% from a year earlier. MP shares ended Friday at $66.63, valuing the company at $11.7 billion. The firm recently began producing neodymium-iron-boron magnets at its Texas facility.
Realty Income Stock Back In Focus As Vanguard Stake Lands Before Q1 Earnings

Realty Income Stock Back In Focus As Vanguard Stake Lands Before Q1 Earnings

2 May 2026
Vanguard Capital Management disclosed a 7.49% stake in Realty Income Corp, holding nearly 69.9 million shares as of March 31, according to an SEC filing. Realty Income will report first-quarter results after the NYSE closes on May 6. Shares closed Friday at $63.81, down 0.67%. Vanguard said the holding is not for activist purposes.
ICICI Bank share price set for Monday test after profit miss and RBI loan review
Previous Story

ICICI Bank share price set for Monday test after profit miss and RBI loan review

ImmunityBio stock set for volatile week after ANKTIVA sales jump and new trial update
Next Story

ImmunityBio stock set for volatile week after ANKTIVA sales jump and new trial update

Go toTop